Thursday, September 21, 2023
Home Authors Posts by Editor / Curator

Editor / Curator

793 POSTS 0 COMMENTS
Roland Rick Perry, Biotech Stock Review
Biotech News

CNS Wellness, Leading Brain Research and Treatment Technology Company Hits Ground...

Editor / Curator -
video
Video

Zestra® Female Sexual Arousal on ABC’s “The View.”

Editor / Curator -
zestra, biotech stock review
eCommerce

Innovus (INNV) Zestra® Female Sexual Arousal Oils Featured in NY Times.

Editor / Curator -
Biotech Stock Review
Health $ Fitness

Christopher E. Rivera Appointed to the Council of Washington Biotechnology &...

Editor / Curator -
All News

Adding VirnetX (VHC) $6.50 To Watch List.

Editor / Curator -
Research

Circle Group / Z-Trim (CRGQ/ZTRM) $2.50. Report.

Editor / Curator -
All News

Hollywood Stock Review Adds SLS Audio to Watch List

Editor / Curator -
Research

Circle Group Holdings (CRGQ) $0.47 Report.

Editor / Curator -
Internet Stock Review
Research

Adding the Jackson Family’s Modern Records (MDNR) to Watch List.

Editor / Curator -
Corporate

Biography | Case Study

Editor / Curator -
1...787980Page 79 of 80

Latest article

20 Minutes with Sekur (SWISF) CEO and Internet Security Expert Alain Ghiai.

Internet News Editor / Curator -
Alain Ghiai, founded the Company and has served as Director and CEO since March 2017. He has served as President and Corporate...

Hapbee’s (HAPB) Revolutionary Sleep Aid Lands on the Shelves of Target.

Client Editor / Curator -
When we first came across Hapbee (HAPB) we described it as having a medical technology (a device) that had the "highest potential...

Adding Cybin (CYBN) to 2024 Top Psychedelic Stocks Watch List.

Psychedelic Stock Review Editor / Curator -
Steve Cohen from Point 72, Acquires 18,950,000 Shares of Cybin.
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.